This effect was mediated through the release of indole‐3‐aldeyde (I3A), a tryptophan catabolite that activates the aryl hydrocarbon receptor (AhR) on CD8+ T cells, enhancing their anti‐tumour response. The gene discussed is CD8A; the disease is neoplasm.